Anne joined the New York office in 2009 and focuses primarily on biopharmaceutical and medical device investments.
Before joining IGC, Anne worked in J.P. Morgan’s Healthcare investment banking group, where she completed various M&A, equity and debt transactions for biotechnology, medical device and diagnostics companies.
Prior to J.P. Morgan, Anne worked in the Healthcare equity research group at UBS covering small- to mid-cap medical technology companies.
Anne is a graduate of the University of Pennsylvania, where she pursued degrees in both Economics from Wharton and in Biomedical Science from the School of Engineering.